{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:52:02Z","timestamp":1791910322122,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.vaccine.2026.129186","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:27:05Z","timestamp":1791235625000},"page":"129186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A phase III randomized study: Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine in healthy adults, adolescents, and children in India and healthy adolescents and children in South Africa"],"prefix":"10.1016","volume":"93","author":[{"given":"Ashish","family":"Bavdekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danaya","family":"Chansinghakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi Mandyam","family":"Dhati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betzana","family":"Zambrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabir Ahmed","family":"Madhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerda","family":"Riekert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep Singh","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonny","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyajit","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlette","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Palkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chalit","family":"Kosolsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anel","family":"Pretorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Lyabis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129186_bb0005","series-title":"Plotkin\u2019s Vaccines","first-page":"664","article-title":"Chapter 39 - Meningococcal capsular group A, C, W, and Y conjugate vaccines","author":"McNamara","year":"2023"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129186_bb0010","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1007\/s40121-024-01063-5","article-title":"Global epidemiology of meningococcal disease-causing serogroups before and after the COVID-19 pandemic: a narrative review","volume":"13","author":"Shen","year":"2024","journal-title":"Infect Dis Ther"},{"issue":"9","key":"10.1016\/j.vaccine.2026.129186_bb0015","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/14760584.2021.1964962","article-title":"A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT","volume":"20","author":"Martinon-Torres","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2026.129186_bb0020","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268823000328","article-title":"Epidemiology of invasive meningococcal disease worldwide from 2010-2019: a literature review","volume":"151","author":"Pardo De Santayana","year":"2023","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2026.129186_bb0025","unstructured":"European Centre for Disease Prevention and Control. Invasive meningococcal disease - Annual epidemiological report for 2023. Updated 15 December 2025. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/invasive-meningococcal-disease-annual-epidemiological-report-2023 [accessed 19 March 2026]."},{"key":"10.1016\/j.vaccine.2026.129186_bb0030","unstructured":"CDC. Meningococcal disease surveillance and trends. Updated 9 May 2025. https:\/\/www.cdc.gov\/meningococcal\/php\/surveillance\/index.html [accessed 19 March 2026]."},{"issue":"12","key":"10.1016\/j.vaccine.2026.129186_bb0035","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1365-3156.2010.02660.x","article-title":"The epidemiology of meningococcal disease in India","volume":"15","author":"Sinclair","year":"2010","journal-title":"Trop Med Int Health"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129186_bb0040","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s40121-020-00323-4","article-title":"A comprehensive review of meningococcal disease burden in India","volume":"9","author":"Dutta","year":"2020","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2026.129186_bb0045","doi-asserted-by":"crossref","DOI":"10.1177\/11786361211053344","article-title":"Meningococcal disease burden in India: a systematic review and meta-analysis","volume":"14","author":"Ghia","year":"2021","journal-title":"Microbiol Insights"},{"issue":"25","key":"10.1016\/j.vaccine.2026.129186_bb0050","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1016\/j.vaccine.2013.04.003","article-title":"An overview of meningococcal disease in India: knowledge gaps and potential solutions","volume":"31","author":"John","year":"2013","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129186_bb0055","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s10096-025-05198-2","article-title":"Molecular detection and serotyping of acute bacterial meningitis pathogens in Indian children","volume":"44","author":"Nagaraj","year":"2025","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129186_bb0060","unstructured":"Govt of India. CBHI. National Health Profile 2020. 15th issue. https:\/\/cbhidghs.mohfw.gov.in\/sites\/default\/files\/NHP\/National-health-2020.pdf [accessed 03 August 2026]."},{"key":"10.1016\/j.vaccine.2026.129186_bb0065","unstructured":"Govt of India. CBHI. National Health Profile 2023. 18th issue. https:\/\/cbhidghs.mohfw.gov.in\/sites\/default\/files\/NHP\/NHP-2023-Last-Final.pdf [accessed 03 August 2026]."},{"issue":"1","key":"10.1016\/j.vaccine.2026.129186_bb0070","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2026.2676385","article-title":"Meningococcal meningitis in India: an expert consensus on use of MCVs","volume":"22","author":"Dutta","year":"2026","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129186_bb0075","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2026712","article-title":"Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India","volume":"18","author":"Dubey","year":"2022","journal-title":"Hum Vaccin Immunother."},{"key":"10.1016\/j.vaccine.2026.129186_bb0080","unstructured":"Public Health Bulletin South Africa. Increase in meningococcal disease in South Africa continues into 2024: clinicians urged to be on alert. https:\/\/www.phbsa.ac.za\/wp-content\/uploads\/2024\/11\/Increase-in-Meningococcal-Disease-in-South-Africa-Report.pdf [accessed 19 March 2026]."},{"key":"10.1016\/j.vaccine.2026.129186_bb0085","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ijid.2022.07.068","article-title":"Case-fatality and sequelae following acute bacterial meningitis in South Africa, 2016 through 2020","volume":"122","author":"Meiring","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129186_bb0090","unstructured":"New report shows surge in meningococcal disease cases in South Africa: a 2024 alert for clinicians. https:\/\/www.meded.co.za\/DocumentPart\/?id=6440 [accessed 15 October 2025]."},{"issue":"9","key":"10.1016\/j.vaccine.2026.129186_bb0095","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/14760584.2021.1964962","article-title":"A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT","volume":"20","author":"Martin\u00f3n-Torres","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2026.129186_bb0100","unstructured":"MenQuadfi. Summary of product characteristics. July 2025. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/menquadfi-epar-product-information_en.pdf [accessed 19 March 2026]."},{"key":"10.1016\/j.vaccine.2026.129186_bb0105","unstructured":"World Health Organization. Prequalification of medical products. MenQuadfi. https:\/\/extranet.who.int\/prequal\/vaccines\/p\/menquadfi [accessed 19 March 2026]."},{"key":"10.1016\/j.vaccine.2026.129186_bb0110","unstructured":"MenQuadfi. Highlights of prescribing information. May 2025. accessed 19 March https:\/\/www.fda.gov\/media\/137306\/download."},{"issue":"10","key":"10.1016\/j.vaccine.2026.129186_bb0115","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/INF.0000000000002832","article-title":"Safety and immunogenicity of a quadrivalent meningococcal conjugate vaccine in healthy meningococcal-na\u00efve children 2-9 years of age: a phase III, randomized study","volume":"39","author":"Baccarini","year":"2020","journal-title":"Pediatr Infect Dis J"},{"issue":"19","key":"10.1016\/j.vaccine.2026.129186_bb0120","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1016\/j.vaccine.2020.03.017","article-title":"A phase II, randomized, immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine, MenACYW-TT, in healthy adolescents in the United States","volume":"38","author":"Chang","year":"2020","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.vaccine.2026.129186_bb0125","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1016\/j.vaccine.2020.06.013","article-title":"Immunogenicity, safety and inter-lot consistency of a meningococcal conjugate vaccine (MenACYW-TT) in adolescents and adults: a phase III randomized study","volume":"38","author":"Dhingra","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129186_bb0130","unstructured":"SANOFI PASTEUR. Menactra transition customer letter. https:\/\/physiciansalliance.com\/wp-content\/uploads\/2022\/04\/Menactra-Transition-Customer-Letter-2022.pdf [accessed 19 March 2026]."},{"key":"10.1016\/j.vaccine.2026.129186_bb0135","unstructured":"Abstracts Book. 14th World Congress of the World Society for Pediatric Infectious Diseases (WSPID 2025). Bangkok, Thailand. 28-31 October 2025. EV176 \/ #332. https:\/\/wspid2025.com\/wp-content\/uploads\/sites\/80\/2025\/11\/WSPID25-ebook-UPDATE-Oct-27.pdf?_gl=1*ejwwoc*_up*MQ..*_ga*MjA5NTAwOTk0LjE3NDUzODUyODc.*_ga_WK40QVE9H6*czE3NzE5OTY0MjIkbzIkZzEkdDE3NzE5OTc3NzQkajE4JGwwJGg2OTQ5NzM4MTI. [accessed 19 March 2026]."},{"issue":"8","key":"10.1016\/j.vaccine.2026.129186_bb0140","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s40121-024-01009-x","article-title":"Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine versus Nimenrix in healthy adolescents: a randomized phase IIIb multicenter study","volume":"13","author":"D\u00edez-Domingo","year":"2024","journal-title":"Infect Dis Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129186_bb0145","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2516949","article-title":"A new quadrivalent meningococcal tetanus toxoid conjugate vaccine: Menquadfi\u00ae (MENACWY-TT)","volume":"21","author":"Dinleyici","year":"2025","journal-title":"Hum Vaccin Immunother"},{"issue":"28","key":"10.1016\/j.vaccine.2026.129186_bb0150","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1016\/j.vaccine.2020.04.067","article-title":"Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in \u226556-year-olds: a phase III randomized study","volume":"38","author":"Esteves-Jaramillo","year":"2020","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129186_bb0155","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s40121-025-01298-w","article-title":"Immunogenicity and safety of quadrivalent meningococcal conjugate vaccine (MenACYW-TT) in potential hajj\/Umrah pilgrims aged\u226556 years: a phase III, open-label study","volume":"15","author":"Dbaibo","year":"2026","journal-title":"Infect Dis Ther"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129186_bb0160","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1080\/21645515.2020.1733869","article-title":"Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a phase II randomized study","volume":"16","author":"Vesikari","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129186_bb0165","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1080\/21645515.2020.1871572","article-title":"Mass gatherings: a review of the scope for meningococcal vaccination in the Indian context","volume":"17","author":"Dubey","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.129186_bb0170","unstructured":"Meningococcal vaccines. Indian Academy of Pediatrics Advisory Committee on Vaccines & Immunization Practices. https:\/\/acvip.org\/professional\/columns\/meningococcal-vaccine. [accessed 19 March 2026]."},{"key":"10.1016\/j.vaccine.2026.129186_bb0175","unstructured":"Vaccine schedule for South Africa - 2025. https:\/\/www.amayeza-info.co.za\/wp-content\/uploads\/2025\/03\/2.-2025-Childhood-vaccine-scheduleN.pdf [accessed 19 March 2026]."},{"issue":"1","key":"10.1016\/j.vaccine.2026.129186_bb0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0008-6215(00)90802-4","article-title":"Structural studies of the Escherichia coli K93 and K53 capsular polysaccharides","volume":"173","author":"Bax","year":"1988","journal-title":"Carbohydr Res"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129186_bb0185","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/jcm.22.2.152-156.1985","article-title":"Risk of group a meningococcal disease: bacterial interference and cross-reactive bacteria among mucosal flora","volume":"22","author":"Filice","year":"1985","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129186_bb0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1574-695X.2002.tb00597.x","article-title":"Analysis of Neisseria lactamica antigens putatively implicated in acquisition of natural immunity to Neisseria meningitidis","volume":"34","author":"Troncoso","year":"2002","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129186_bb0195","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1286-4579(00)00356-7","article-title":"Epidemiology and pathogenesis of Neisseria meningitidis","volume":"2","author":"Tzeng","year":"2000","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2026.129186_bb0200","unstructured":"World Health Organization. Defeating meningitis by 2030: a global road map. https:\/\/www.who.int\/publications\/i\/item\/9789240026407 [accessed 19 March 2026]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:22:29Z","timestamp":1791908549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26009953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":40,"alternative-id":["S0264410X26009953"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129186","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase III randomized study: Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine in healthy adults, adolescents, and children in India and healthy adolescents and children in South Africa","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129186"}}